© 1998-2001 MONKEYmedia, Inc. All rights reserved.
Alameda, CA, June 29, 1998 - Chiron Informatics, a business unit of Chiron Corporation (NASDAQ:CHIR), will introduce HIV PromptChartTM, a care management software tool, at the 12th Annual International AIDS Conference in Geneva. The first in a class of web-based applications, PromptChart creates, organizes and manages a longitudinal database of critical patient data and presents that information in disease specific clinical views for physicians to develop more effective treatment strategies.
HIV PromptChart is a web-based software tool that gives physicians easy access to critical information needed to develop effective treatment strategies. In the context of clinical care it provides a framework for discussion of the patient's ongoing therapeutic response and the management of complications. Using HIV PromptChart can decrease the time required to review critical laboratory values by providing concise visual tools that track longitudinal changes in relevant markers, such as viral load and CD4. PromptChart provides patient-specific reminders and alerts based on physician treatment guidelines. These alerts span the continuum from prophylaxis treatment recommendations through reminders of routine test needs and vaccines. Using HIV PromptChart can enhance regimen compliance by providing physicians with customized, patient specific summaries and drug calendars that clearly specify when and how patients should take prescribed medications.
"PromptChart tracks all the patient's CD4 count and HIV RNA data in an easy-to-read graphical format, coupled with a time-line of the patient's prior and current antiretroviral therapy," said Carol Kemper, M.D., Associate Medical Director, AIDS Health Services and Clinical Assistant Professor of Medicine at Stanford University. "With one quick glance, the patient's treatment history, nadir HIV RNA response to therapy, the rate and duration of that response, the occurrence of viral recrudescence during therapy, as well as any possible relationship to the occurrence of intercurrent illness, infection, or immunization is immediately available."
"PromptChart offers both the provider and the patient the ability to manage the cooperative care delivery process, improving communication and compliance with complex treatment strategies and protocols," said Peter A. Thompson, M.D. FACP, vice president and general manager of Chiron Informatics. "Chiron Informatics is leading the industry in computer-based decision support tools for developing and distributing clinical guidelines and protocols. PromptChart will ultimately serve as a web-based or browser-based graphical user interface for underlying platforms of executable code from other Chiron Informatics product lines or product classes."
PromptChart marks the first knowledge based, disease-specific, information management service from Chiron Informatics and will initially be released in the United States in the summer of 1998 with European releases planned in the spring of 1999. The software is organized into two modules - the Visit Preparation Module, expected to be generally available by late summer and the Treatment Module, which is expected to be available in December 1998.
Chiron Informatics is developing state-of-the-art decision support, data mining technology and medical management consulting services that facilitate the implementation of comprehensive practice guidelines for health care delivery systems. Chiron Informatics leverages strong internal competencies in biomedical science, health services research, informatics, and data analytics.
Chiron Corporation is a science-driven, market-directed healthcare company that combines diagnostic, vaccine and therapeutic strategies for controlling disease. Chiron participates in three global markets: diagnostics including immunodiagnostics, critical care diagnostics, and new quantitative probe tests; pediatric and adult vaccines and therapeutics, with an emphasis on oncology and infectious disease. Chiron also has research programs underway in gene therapy and gene transfer, combinatorial chemistry, cardiovascular disease, critical care and medical informatics.
This news release contains forward-looking statements that involve risks
and uncertainties, which might affect the initiation and completion of clinical
trials and the launch of products. A full discussion of the companies' operations
and financial condition, including factors that may affect their business and
future prospects, is contained in documents the companies file with the SEC,
such as form 10-Q and 10-K and 40F reports. These documents identify important
factors that could cause the companies' actual performance to differ from current
expectations, including the outcome of clinical trials, regulatory review, manufacturing
capabilities and marketing effectiveness.
This press release is reproduced from the PromptChart web site. © 1998
Chiron Informatics.